SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,000 | -79.7% | 12,222 | -80.4% | 0.00% | -100.0% |
| Q4 2021 | $79,000 | -44.4% | 62,257 | -4.5% | 0.00% | -50.0% |
| Q3 2021 | $142,000 | -42.0% | 65,157 | -0.5% | 0.00% | -33.3% |
| Q2 2021 | $245,000 | +26.9% | 65,457 | +10.5% | 0.00% | +50.0% |
| Q1 2021 | $193,000 | -2.5% | 59,217 | +2.1% | 0.00% | -33.3% |
| Q4 2020 | $198,000 | -17.5% | 58,017 | -1.6% | 0.00% | -25.0% |
| Q3 2020 | $240,000 | +55.8% | 58,934 | +29.7% | 0.00% | +100.0% |
| Q2 2020 | $154,000 | +45.3% | 45,434 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $106,000 | -35.8% | 45,434 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $165,000 | -53.4% | 45,434 | +6.6% | 0.00% | -60.0% |
| Q3 2019 | $354,000 | -1.9% | 42,634 | +1.7% | 0.01% | 0.0% |
| Q2 2019 | $361,000 | -14.3% | 41,934 | +6.6% | 0.01% | -16.7% |
| Q1 2019 | $421,000 | +24.6% | 39,337 | +1.8% | 0.01% | +20.0% |
| Q4 2018 | $338,000 | – | 38,626 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |